The economics of comparative effectiveness research
Citation Manager Formats
Make Comment
See Comments
![Loading Loading](https://n.neurology.org/sites/all/modules/contrib/panels_ajax_tab/images/loading.gif)
This article requires a subscription to view the full text. If you have a subscription you may use the login form below to view the article. Access to this article can also be purchased.
Comparative effectiveness research (CER)—evidence that compares alternative methods of prevention, diagnosis, treatment, and monitoring or care delivery1—holds the promise of improving care and reducing health care costs. In this issue of Neurology®, French and England2 highlight how CER can improve care by informing clinical practice and guideline development. Here we examine whether and how CER may affect both the level and growth of health care expenditures.
In 2008, the United States spent more than $2.3 trillion or over 16% of its gross domestic product on health care,3 far more than any other country. However, by many health metrics, the United States lags behind its peers.4 Maximizing the value of health care expenditures, the majority of which goes to health care delivery,3 is thus an important objective, but to date only 0.1% of health care spending has been devoted to research aimed at improving health care delivery.5 This funding may increase; the Institute of Medicine identified health delivery as the top priority for $1.1 billion of new federal funding for CER as part of the American Recovery and Reinvestment Act of 2009. By identifying cost-effective ways to deliver care, CER may reduce the level of health care spending. Delivering health care to those with neurologic …
AAN Members
We have changed the login procedure to improve access between AAN.com and the Neurology journals. If you are experiencing issues, please log out of AAN.com and clear history and cookies. (For instructions by browser, please click the instruction pages below). After clearing, choose preferred Journal and select login for AAN Members. You will be redirected to a login page where you can log in with your AAN ID number and password. When you are returned to the Journal, your name should appear at the top right of the page.
AAN Non-Member Subscribers
Purchase access
For assistance, please contact:
AAN Members (800) 879-1960 or (612) 928-6000 (International)
Non-AAN Member subscribers (800) 638-3030 or (301) 223-2300 option 3, select 1 (international)
Sign Up
Information on how to subscribe to Neurology and Neurology: Clinical Practice can be found here
Purchase
Individual access to articles is available through the Add to Cart option on the article page. Access for 1 day (from the computer you are currently using) is US$ 39.00. Pay-per-view content is for the use of the payee only, and content may not be further distributed by print or electronic means. The payee may view, download, and/or print the article for his/her personal, scholarly, research, and educational use. Distributing copies (electronic or otherwise) of the article is not allowed.
Letters: Rapid online correspondence
REQUIREMENTS
You must ensure that your Disclosures have been updated within the previous six months. Please go to our Submission Site to add or update your Disclosure information.
Your co-authors must send a completed Publishing Agreement Form to Neurology Staff (not necessary for the lead/corresponding author as the form below will suffice) before you upload your comment.
If you are responding to a comment that was written about an article you originally authored:
You (and co-authors) do not need to fill out forms or check disclosures as author forms are still valid
and apply to letter.
Submission specifications:
- Submissions must be < 200 words with < 5 references. Reference 1 must be the article on which you are commenting.
- Submissions should not have more than 5 authors. (Exception: original author replies can include all original authors of the article)
- Submit only on articles published within 6 months of issue date.
- Do not be redundant. Read any comments already posted on the article prior to submission.
- Submitted comments are subject to editing and editor review prior to posting.
You May Also be Interested in
Differences in Age-related Retinal and Cortical Atrophy Rates in Multiple Sclerosis
Prof. Massimo Filippi and Dr. Paolo Preziosa
► Watch
Related Articles
Topics Discussed
Alert Me
Recommended articles
-
Resident and Fellow Section
Emerging Subspecialties in Neurology: Health services researchNabila Dahodwala, Ana-Claire Meyer et al.Neurology, March 08, 2010 -
Presidential Address
Challenges for Neurological Care, 2001–2030Francis I. Kittredge, Jr. et al.Neurology, August 14, 2001 -
Special Article
Quality improvement in neurologyNeurology Outcomes Quality Measurement SetJason J. Sico, Aarti Sarwal, Sarah M. Benish et al.Neurology, May 12, 2020 -
Special Article
Invited Article: Comparative effectiveness research, evidence-based medicine, and the AANJacqueline A. French, John D. England et al.Neurology, August 09, 2010